KNTPF
Price
$0.27
Change
+$0.01 (+3.85%)
Updated
Sep 30 closing price
Capitalization
162.02M
Intraday BUY SELL Signals
RLFTY
Price
$4.90
Change
+$0.49 (+11.11%)
Updated
Oct 8 closing price
Capitalization
222.25M
Intraday BUY SELL Signals
Interact to see
Advertisement

KNTPF vs RLFTY

Header iconKNTPF vs RLFTY Comparison
Open Charts KNTPF vs RLFTYBanner chart's image
KINTOR PHARMACEUTICAL
Price$0.27
Change+$0.01 (+3.85%)
Volume$200
Capitalization162.02M
RELIEF THERAPEUTICS HLDG AG
Price$4.90
Change+$0.49 (+11.11%)
Volume$100
Capitalization222.25M
KNTPF vs RLFTY Comparison Chart in %
KNTPF
Daily Signal:
Gain/Loss:
RLFTY
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
KNTPF vs. RLFTY commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KNTPF is a Buy and RLFTY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (KNTPF: $0.35 vs. RLFTY: $1.41)
Brand notoriety: KNTPF and RLFTY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KNTPF: 88% vs. RLFTY: 13%
Market capitalization -- KNTPF: $162.02M vs. RLFTY: $222.25M
KNTPF [@Biotechnology] is valued at $162.02M. RLFTY’s [@Biotechnology] market capitalization is $222.25M. The market cap for tickers in the [@Biotechnology] industry ranges from $119.38B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KNTPF’s FA Score shows that 0 FA rating(s) are green whileRLFTY’s FA Score has 1 green FA rating(s).

  • KNTPF’s FA Score: 0 green, 5 red.
  • RLFTY’s FA Score: 1 green, 4 red.
According to our system of comparison, KNTPF is a better buy in the long-term than RLFTY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KNTPF’s TA Score shows that 2 TA indicator(s) are bullish while RLFTY’s TA Score has 3 bullish TA indicator(s).

  • KNTPF’s TA Score: 2 bullish, 5 bearish.
  • RLFTY’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, RLFTY is a better buy in the short-term than KNTPF.

Price Growth

KNTPF (@Biotechnology) experienced а 0.00% price change this week, while RLFTY (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.56%. For the same industry, the average monthly price growth was +1.40%, and the average quarterly price growth was +33.10%.

Industries' Descriptions

@Biotechnology (-2.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RLFTY($222M) has a higher market cap than KNTPF($162M). KNTPF YTD gains are higher at: 61.688 vs. RLFTY (-50.000).
KNTPFRLFTYKNTPF / RLFTY
Capitalization162M222M73%
EBITDAN/A-17.89M-
Gain YTD61.688-50.000-123%
P/E RatioN/AN/A-
RevenueN/A4.05M-
Total CashN/A12.5M-
Total DebtN/A1.9M-
TECHNICAL ANALYSIS
Technical Analysis
KNTPFRLFTY
RSI
ODDS (%)
Bearish Trend 2 days ago
50%
Bullish Trend 2 days ago
63%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
64%
Bullish Trend 2 days ago
57%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
35%
Bullish Trend 2 days ago
47%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
26%
Bearish Trend 2 days ago
77%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
KNTPF
Daily Signal:
Gain/Loss:
RLFTY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WMKSX15.600.01
+0.06%
WesMark Small Company Fund
CSIIX9.16-0.01
-0.11%
Copeland International Small Cap I
WSCRX35.30-0.20
-0.56%
Allspring Small Company Growth R6
HRAUX71.88-0.91
-1.25%
Carillon Eagle Mid Cap Growth R6
SELCX41.07-0.66
-1.58%
SEI Large Cap Growth F (SIMT)

KNTPF and

Correlation & Price change

A.I.dvisor tells us that KNTPF and MLEC have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KNTPF and MLEC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KNTPF
1D Price
Change %
KNTPF100%
N/A
MLEC - KNTPF
27%
Poorly correlated
-5.40%
KNSA - KNTPF
20%
Poorly correlated
+0.65%
UNCY - KNTPF
20%
Poorly correlated
+7.29%
RLFTY - KNTPF
20%
Poorly correlated
N/A
BCTX - KNTPF
9%
Poorly correlated
-3.13%
More

RLFTY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLFTY has been loosely correlated with RLFTF. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if RLFTY jumps, then RLFTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLFTY
1D Price
Change %
RLFTY100%
N/A
RLFTF - RLFTY
43%
Loosely correlated
N/A
ORKA - RLFTY
23%
Poorly correlated
+0.73%
PCVX - RLFTY
21%
Poorly correlated
-2.91%
HOTH - RLFTY
21%
Poorly correlated
-4.32%
NERV - RLFTY
21%
Poorly correlated
+5.34%
More